1887

Journal of General Virology header logo

Volume 94, Issue 12

Presence of subclinical infection in gene-targeted human prion protein transgenic mice exposed to atypical bovine spongiform encephalopathy Free

Abstract

The transmission of bovine spongiform encephalopathy (BSE) to humans, leading to variant Creutzfeldt–Jakob disease has demonstrated that cattle transmissible spongiform encephalopathies (TSEs) can pose a risk to human health. Until recently, TSE disease in cattle was thought to be caused by a single agent strain, BSE, also known as classical BSE, or BSE-C. However, due to the initiation of a large-scale surveillance programme throughout Europe, two atypical BSE strains, bovine amyloidotic spongiform encephalopathy (BASE, also named BSE-L) and BSE-H have since been discovered. To model the risk to human health, we previously inoculated these two forms of atypical BSE (BASE and BSE-H) into gene-targeted transgenic (Tg) mice expressing the human prion protein (PrP) (HuTg) but were unable to detect any signs of TSE pathology in these mice. However, despite the absence of TSE pathology, upon subpassage of some BASE-challenged HuTg mice, a TSE was observed in recipient gene-targeted bovine PrP Tg (Bov6) mice but not in HuTg mice. Disease transmission from apparently healthy individuals indicates the presence of subclinical BASE infection in mice expressing human PrP that cannot be identified by current diagnostic methods. However, due to the lack of transmission to HuTg mice on subpassage, the efficiency of mouse-to-mouse transmission of BASE appears to be low when mice express human rather than bovine PrP.

  • Received:
  • Accepted:
  • Published Online:
© 2013 SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.052738-0
2013-12-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/12/2819.html?itemId=/content/journal/jgv/10.1099/vir.0.052738-0&mimeType=html&fmt=ahah

References

  1. Andréoletti O., Orge L., Benestad S. L., Beringue V., Litaise C., Simon S., Le Dur A., Laude H., Simmons H.other authors 2011; Atypical/Nor98 scrapie infectivity in sheep peripheral tissues. PLoS Pathog 7:e1001285 [View Article][PubMed]
     [Google Scholar]
  2. Baron T., Vulin J., Biacabe A.-G., Lakhdar L., Verchere J., Torres J.-M., Bencsik A. 2011; Emergence of classical BSE strain properties during serial passages of H-BSE in wild-type mice. PLoS ONE 6:e15839 [View Article][PubMed]
     [Google Scholar]
  3. Barron R. M., Campbell S. L., King D., Bellon A., Chapman K. E., Williamson R. A., Manson J. C. 2007; High titres of TSE infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 282:35878–35886 [View Article][PubMed]
     [Google Scholar]
  4. Béringue V., Bencsik A., Le Dur A., Reine F., Laï T. L., Chenais N., Tilly G., Biacabé A.-G., Baron T.other authors 2006; Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy. PLoS Pathog 2:e112 [View Article][PubMed]
     [Google Scholar]
  5. Béringue V., Andréoletti O., Le Dur A., Essalmani R., Vilotte J. L., Lacroux C., Reine F., Herzog L., Biacabé A. G.other authors 2007; A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission. J Neurosci 27:6965–6971 [View Article][PubMed]
     [Google Scholar]
  6. Béringue V., Herzog L., Reine F., Le Dur A., Casalone C., Vilotte J. L., Laude H. 2008; Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerg Infect Dis 14:1898–1901 [View Article][PubMed]
     [Google Scholar]
  7. Biacabe A. G., Laplanche J. L., Ryder S., Baron T. 2004; Distinct molecular phenotypes in bovine prion diseases. EMBO Rep 5:110–115 [View Article][PubMed]
     [Google Scholar]
  8. Bishop M. T., Hart P., Aitchison L., Baybutt H. N., Plinston C., Thomson V., Tuzi N. L., Head M. W., Ironside J. W., Will R. G. 2006; Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5:393–398 [View Article][PubMed]
     [Google Scholar]
  9. Brown P., McShane L. M., Zanusso G., Detwile L. 2006; On the question of sporadic or atypical bovine spongiform encephalopathy and Creutzfeldt–Jakob disease. Emerg Infect Dis 12:1816–1821 [View Article][PubMed]
     [Google Scholar]
  10. Bruce M. E., Will R. G., Ironside J. W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J.other authors 1997; Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498–501 [View Article][PubMed]
     [Google Scholar]
  11. Buschmann A., Gretzschel A., Biacabe A. G., Schiebel K., Corona C., Hoffmann C., Eiden M., Baron T., Casalone C., Groschup M. H. 2006; Atypical BSE in Germany – proof of transmissibility and biochemical characterization. Vet Microbiol 117:103–116 [View Article][PubMed]
     [Google Scholar]
  12. Capobianco R., Casalone C., Suardi S., Mangieri M., Miccolo C., Limido L., Catania M., Rossi G., Di Fede G.other authors 2007; Conversion of the BASE prion strain into the BSE strain: the origin of BSE?. PLoS Pathog 3:e31 [View Article][PubMed]
     [Google Scholar]
  13. Casalone C., Zanusso G., Acutis P., Ferrari S., Capucci L., Tagliavini F., Monaco S., Caramelli M. 2004; Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt–Jakob disease. Proc Natl Acad Sci U S A 101:3065–3070 [View Article][PubMed]
     [Google Scholar]
  14. Dickinson A. G., Meikle V. M., Fraser H. 1968; Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J Comp Pathol 78:293–299 [View Article][PubMed]
     [Google Scholar]
  15. Dudas S., Yang J., Graham C., Czub M., McAllister T. A., Coulthart M. B., Czub S. 2010; Molecular, biochemical and genetic characteristics of BSE in Canada. PLoS ONE 5:e10638 [View Article][PubMed]
     [Google Scholar]
  16. Fraser H., Dickinson A. G. 1967; Distribution of experimentally induced scrapie lesions in the brain. Nature 216:1310–1311 [View Article][PubMed]
     [Google Scholar]
  17. Hagiwara K., Yamakawa Y., Sato Y., Nakamura Y., Tobiume M., Shinagawa M., Sata T. 2007; Accumulation of mono-glycosylated form-rich, plaque-forming PrPSc in the second atypical bovine spongiform encephalopathy case in Japan. Jpn J Infect Dis 60:305–308[PubMed]
     [Google Scholar]
  18. Hill A. F., Collinge J. 2003a; Subclinical prion infection in humans and animals. Br Med Bull 66:161–170 [View Article][PubMed]
     [Google Scholar]
  19. Hill A. F., Collinge J. 2003b; Subclinical prion infection. Trends Microbiol 11:578–584 [View Article][PubMed]
     [Google Scholar]
  20. Hill A. F., Desbruslais M., Joiner S., Sidle K. C. L., Gowland I., Collinge J., Doey L. J., Lantos P. 1997; The same prion strain causes vCJD and BSE. Nature 389:448–450, 526 [View Article][PubMed]
     [Google Scholar]
  21. Jacobs J. G., Langeveld J. P., Biacabe A. G., Acutis P. L., Polak M. P., Gavier-Widen D., Buschmann A., Caramelli M., Casalone C.other authors 2007; Molecular discrimination of atypical bovine spongiform encephalopathy strains from a geographical region spanning a wide area in Europe. J Clin Microbiol 45:1821–1829 [View Article][PubMed]
     [Google Scholar]
  22. Kong Q., Zheng M., Casalone C., Qing L., Huang S., Chakraborty B., Wang P., Chen F., Cali I.other authors 2008; Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol 82:3697–3701 [View Article][PubMed]
     [Google Scholar]
  23. Okada H., Masujin K., Iwamaru Y., Imamura M., Matsuura Y., Mohri S., Czub S., Yokoyama T. 2010; Experimental transmission of h-type bovine spongiform encephalopathy to bovinized transgenic mice. Vet Pathol 48:942–947 [View Article][PubMed]
     [Google Scholar]
  24. Parchi P., Giese A., Capellari S., Brown P., Schulz-Schaeffer W., Windl O., Zerr I., Budka H., Kopp N.other authors 1999; Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233 [View Article][PubMed]
     [Google Scholar]
  25. Plinston C., Hart P., Chong A., Hunter N., Foster J., Piccardo P., Manson J. C., Barron R. M. 2011; Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy infection following passage in sheep. J Virol 85:1174–1181 [View Article][PubMed]
     [Google Scholar]
  26. Race R., Raines A., Raymond G. J., Caughey B., Chesebro B. 2001; Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt–Jakob disease in humans. J Virol 75:10106–10112 [View Article][PubMed]
     [Google Scholar]
  27. Race R., Meade-White K., Raines A., Raymond G. J., Caughey B., Chesebro B. 2002; Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J Infect Dis 186:Suppl. 2S166–S170 [View Article][PubMed]
     [Google Scholar]
  28. Richt J. A., Kunkle R. A., Alt D., Nicholson E. M., Hamir A. N., Czub S., Kluge J., Davis A. J., Hall S. M. 2007; Identification and characterization of two bovine spongiform encephalopathy cases diagnosed in the United States. J Vet Diagn Invest 19:142–154 [View Article][PubMed]
     [Google Scholar]
  29. Safar J. G., Kellings K., Serban A., Groth D., Cleaver J. E., Prusiner S. B., Riesner D. 2005a; Search for a prion-specific nucleic acid. J Virol 79:10796–10806 [View Article][PubMed]
     [Google Scholar]
  30. Safar J. G., DeArmond S. J., Kociuba K., Deering C., Didorenko S., Bouzamondo-Bernstein E., Prusiner S. B., Tremblay P. 2005b; Prion clearance in bigenic mice. J Gen Virol 86:2913–2923 [View Article][PubMed]
     [Google Scholar]
  31. Stack M. J., Focosi-Snyman R., Cawthraw S., Davis L., Chaplin M. J., Burke P. J. 2009; Third atypical BSE case in Great Britain with an H-type molecular profile. Vet Rec 165:605–606 [View Article][PubMed]
     [Google Scholar]
  32. Wells G. A., Scott A. C., Johnson C. T., Gunning R. F., Hancock R. D., Jeffrey M., Dawson M., Bradley R. 1987; A novel progressive spongiform encephalopathy in cattle. Vet Rec 121:419–420 [View Article][PubMed]
     [Google Scholar]
  33. Wemheuer W. M., Benestad S. L., Wrede A., Wemheuer W. E., Brenig B., Bratberg B., Schulz-Schaeffer W. J. 2011; PrPSc spreading patterns in the brain of sheep linked to different prion types. Vet Res 42:32 [View Article][PubMed]
     [Google Scholar]
  34. Wilson R., Hart P., Piccardo P., Hunter N., Casalone C., Baron T., Barron R. 2012a; Bovine PrP expression levels in transgenic mice influence transmission characteristics of atypical BSE. J Gen Virol 93:1132–1140 [View Article][PubMed]
     [Google Scholar]
  35. Wilson R., Plinston C., Hunter N., Casalone C., Corona C., Tagliavini F., Suardi S., Ruggerone M., Moda F.other authors 2012b; Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. J Gen Virol 93:1624–1629 [View Article][PubMed]
     [Google Scholar]
  36. Zeidler M., Stewart G., Cousens S. N., Estibeiro K., Will R. G. 1997; Codon 129 genotype and new variant CJD. Lancet 350:668 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.052738-0
Loading
Presence of subclinical infection in gene-targeted human prion protein transgenic mice exposed to atypical bovine spongiform encephalopathy
J. Gen. Virol. 94, 2819 (2013); https://doi.org/10.1099/vir.0.052738-0
/content/journal/jgv/10.1099/vir.0.052738-0
/content/journal/jgv/10.1099/vir.0.052738-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error